A Phase 2 Randomized, Placebo-controlled, Double-blind Study of the Efficacy of MORAb-009 in Combination With Gemcitabine in Patients With Advanced Pancreatic Cancer.
Phase of Trial: Phase II
Latest Information Update: 01 Apr 2016
At a glance
- Drugs Amatuximab (Primary) ; Gemcitabine
- Indications Pancreatic cancer
- Focus Therapeutic Use
- Sponsors Morphotek
- 07 Jun 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 25 Mar 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 27 Aug 2008 Trial sites have been opened in the EU, as reported in a Morphotek media release.